United States Securities and Exchange Commission · EDGAR Accession 0001787792-26-000003

Form C-U

Offering Progress Update — Regulation Crowdfunding
Campaign file 020-36769
Issuer CIK 1787792
Raising via DEALMAKER SECURITIES LLC

Fisher Wallace Laboratories, Inc.

CorporationDEIncorporated 2019BROOKLYN, NYfisherwallace.com
Progress updateThe Offering ended on February 20, 2026, having closed on $127,683.74 of funds although final accounting has yet to take place.
A

The Offering

as disclosed in this filing
Common Stock
$11.21
$103,505
$2,587,498
February 20, 2026
Expired 114 days ago
$0max $2,587,498

Target is 4% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Revenue −98% YoYBurn decreasingDebt / assets 996%5 employees
Line itemMost recent FYPrior FYΔ
Revenue47,4122,019,527▼ 98%
Cost of goods sold3,012350,736▼ 99%
Net income(1,579,900)(1,644,382)▲ burn
Total assets154,382361,017▼ 57%
Cash & equivalents41,626311,160▼ 87%
Accounts receivable00
Short-term debt596,720569,243▲ 5%
Long-term debt940,656866,830▲ 9%
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-36769 · all filings under this campaign
Loading campaign history…